logo-loader
viewIXICO PLC

Full interview: IXICO's Alison Howie discusses support for the AD Neuroimaging Initiative

Ixico PLC's (LON:IXI) Alison Howie tells Proactive London's Andrew Scott they're to provide funding and expertise for the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Two of IXICO's scientists will join the private partner scientific board of ADNI which is looking to develop clinical, imaging, genetic and biochemical biomarkers for the early detection and tracking of Alzheimer's disease.

Quick facts: IXICO PLC

Price: 48.5 GBX

AIM:IXI
Market: AIM
Market Cap: £22.84 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IXICO PLC named herein, including the promotion by the Company of IXICO PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

IXICO's Lammert Albers discusses expanded contract for imaging services with...

IXICO PLC's (LON:IXI) chief business officer Lammert Albers talks Proactive's Andrew Scott through an extended contract they've secured with Vaccinex Inc (NASDAQ:VCNX). It's to provide services on a trial of a potential treatment for Alzheimer’s disease. The company’s digital platform and...

1 week, 2 days ago

2 min read